Ex-vivo expanded allogeneic γδT cells

BIOLOGICAL2 trials

Sponsors

Beijing 302 Hospital, Institute of Hematology & Blood Diseases Hospital, China

Conditions

Hepatocellular CarcinomaNon-Hodgkin's Lymphoma (NHL)Peripheral T Cell Lymphoma (PTCL)

Early Phase 1

Allogeneic Gammadelta T Cells (γδ T Cells) Cell Immunotherapy in Phase 1 Hepatocellular Carcinoma Clinical Trial

Beijing 302 HospitalHepatocellular Carcinoma

Start: 2020-08-15End: 2021-08-15Target: 8Updated: 2020-08-19

Allogeneic γδ T Cells Immunotherapy in r/r Non-Hodgkin's Lymphoma (NHL) or Peripheral T Cell Lymphomas (PTCL) Patients

Institute of Hematology & Blood Diseases Hospital, ChinaNon-Hodgkin's Lymphoma (NHL), Peripheral T Cell Lymphoma (PTCL)

Start: 2020-12-31End: 2023-12-25Target: 10Updated: 2021-01-06